Stock Comparison

CRL vs TMO

Charles River Laboratories and Thermo Fisher Scientific Inc side by side — valuation, profitability, growth and risk.

CRL

Charles River Laboratories

Healthcare

TMO

Thermo Fisher Scientific Inc

Healthcare

Valuation

Market Cap

$12.97B

$218.35B

P/E (TTM)

—

31.8

Forward P/E

24.5

23.5

Price/Sales

3.3

4.7

Price/Book

4.6

4.2

EV/EBITDA

71.0

21.3

Dividend Yield

—

0.30%

Profitability

Net Margin

-4.59%

15.18%

Operating Margin

11.77%

17.76%

Return on Equity

-7.52%

13.50%

Return on Assets

4.11%

5.13%

Growth (YoY)

Revenue Growth

-2.70%

10.50%

Earnings Growth

-17.30%

9.40%

Price & Risk

Beta

1.4

0.8

52-Week High

$284.41

$638.80

52-Week Low

$145.57

$438.34

Analyst Target

$270.86

$631.42

Compare CRL and TMO your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.